Latest stories on CMPS
Strata Mental Health Solutions awarded training grant by Compass Pathways
The Fly59 · neutralgeneral
Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training
PR Newswire63 · neutralproduct/pr
Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval COMP360 Provider Training
StockTitan56 · neutralproduct/pr
Compass Pathways to Participate in Investor Conferences the Week of September 14th
StockTitan56 · neutralgeneral
Oppenheimer reiterates Compass Pathways stock rating on trial data
Investing.com Analyst Ratings56 · neutralanalyst
Jefferies reiterates Compass Pathways stock rating on TRD approval confidence
Investing.com Analyst Ratings56 · neutralanalyst
Compass Pathways stock shows durable results in depression trial
Investing.com Analyst Ratings67 · bullishproduct/pr
CMPS Stock Defies Market Selloff After Compass Pathways Psilocybin Trial Success Pointing To 2027 Launch
Stocktwits News73 · bullishproduct/pr
Compass Pathways reports 52-week results from Phase 3 COMP005 trial
The Fly59 · neutralproduct/pr
CMPS Stock Rallies On Launch-Prep Push Ahead Of FDA Psychedelics Hearing
Stocktwits News67 · bullishproduct/pr
Compass Pathways to Debut U.S. HCP Education Campaign and Present New HEOR Data at Psych Congress 2026
StockTitan56 · neutralproduct/pr
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree
StockTitan67 · bullishproduct/pr
Compass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 2026
StockTitan55 · neutralgeneral
Compass: Operating Margin Is Improving, But Not By Much
Seeking Alpha32 · bearishanalyst
Compass Pathways: There Are Different Scenarios To Be Considered In Clinical, Regulatory, And Commercialization
Seeking Alpha73 · bullishanalyst
Compass Pathways: Still A Buy, But The Exit Just Got Complicated
Seeking Alpha56 · neutralanalyst
CMPS Stock Clocks 25% Gains In August Ahead Of Application Filing For Drug, FDA Hearing On Psychedelics
Stocktwits News73 · bullishproduct/pr
Compass Pathways (CMPS) Earnings Call Highlights COMP360’s Path
TipRanks65 · bullishearnings
COMPASS Pathways (CMPS) Q2 2026 Earnings Call Transcript
The Motley Fool56 · neutralearnings
Compass Pathways Price Target Lowered To 65 From 70 At H C Wainwright
The Fly38 · neutralanalyst
Compass Pathways Price Target Raised To 18 From 17 At Morgan Stanley
The Fly61 · neutralanalyst
Psychedelic: Compass Pathways, GH Research report quarterly earnings
The Fly50 · neutralearnings